You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
希瑪眼科(03309.HK)擬2674.5萬港元收購醫學執業業務
格隆匯 08-28 17:21

格隆匯 8 月 28日丨希瑪眼科(03309.HK)公告,於2020年8月28日 ,香港國際眼科醫療(公司的全資附屬公司)與賣方張明權醫生訂立購買協議,據此,香港國際眼科醫療已有條件同意按代價收購,而賣方已有條件同意出售執業業務及資產。代價將部分以現金支付及部分由公司按代價股份價格向賣方配發及發行代價股份支付。

收購事項的最高代價將為2674.5萬港元。 (1)現金1528.1萬港元,將於完成後5個營業日內使用集團內部財務資源償付;(2)1136.4萬港元,透過公司於完成後10個營業日內按每股代價股份約6.135港元的價格向賣方配發及發行1,852,322股代價股份償付;(3)最多10萬港元用於收購緊隨於完成日期當日營業時間結束後診所物業內所持有的藥物,並將按買方與賣方於完成後將另行協定的原始購買成償付。

於完成後,賣方將持有公司經配發及發行代價股份擴大後的已發行股約0.16%。

香港國際眼科醫療繼續於眼科服務取得驕人業績併產生經常性收入。經計及香港國際眼科醫療將為集團貢獻可觀利潤的卓越財務表現後,收購執業業務及賣方加入作為香港希瑪國際眼科醫療集團(中國)有限公司及香港國際眼科醫療的合夥人為公司帶來龐大機遇,以進一步擴大市場份額並可更好地利用集團的手術中心及公司的聯合醫務人員團隊。收購事項可令集團擴大收益來源並高效利用財務資源。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account